Skip to main content

Table 3 Vital Signs and Liver Function Tests

From: Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial

Parameter

Pre-Treatment (= day -7) mean ± sd

Post-Treatment (last visit) mean ± sd

Number of Patients

16

14

Systolic Blood Pressure, mm Hg

135 ± 13

132 ± 10

Diastolic Blood Pressure, mm Hg

85 ± 9

83 ± 6

Pulse, beats/min

80 ± 5

79 ± 9

AST, IU/L

31.9 ± 14.6

27.6 ± 22.7

Total Bilirubin, mg/dL

0.6 ± 0.3

0.6 ± 0.3